Please assess the completion status of the following clinical trial:

Trial Title: Intravenous Lidocaine and Postoperative Outcomes After Cardiac Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 18-90 years old~* Scheduled for cardiac surgery requiring cardiopulmonary bypass~* Written informed consent~Exclusion Criteria:~* Off-pump surgical procedures~* Anticipated deep hypothermic circulatory arrest~* Any contraindications to the proposed interventions including lidocaine allergy~* History of preoperative atrial fibrillation~* Baseline Screening revealing preexisting dementia or delirium~* Preoperative liver failure defined as Child-Pugh Score \> 6

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 90 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Intravenous Lidocaine group
- Placebo (Type: PLACEBO_COMPARATOR): Intravenous placebo Group - Placebo is administered intravenously throughout surgery and during the 24 hours following surgery

Based on this trial design, predict the completion outcome and termination type (if applicable).